BASF vs. Sharda USA: Herbicide Patent Case Dismissed in 43 Days
What would you like to do next?
Choose your path based on your current needs:
📋 Case Summary
| Case Name | BASF Agricultural Solutions US LLC v. Sharda USA LLC |
| Case Number | 2:25-cv-06635 (E.D. Pa.) |
| Court | U.S. District Court for the Eastern District of Pennsylvania |
| Duration | Nov 2025 – Jan 2026 43 days |
| Outcome | Voluntary Dismissal – No Damages |
| Patents at Issue | |
| Accused Products | Sharda USA’s saflufenacil-containing formulations |
Case Overview
The Parties
⚖️ Plaintiff
U.S. agricultural division of BASF SE, a leading chemical manufacturer with a substantial agrochemical IP portfolio, including saflufenacil.
🛡️ Defendant
U.S. arm of Sharda Cropchem Limited, specializing in registering and commercializing generic crop protection products, frequently involved in agrochemical patent disputes.
The Patent at Issue
This case involved a single U.S. patent covering saflufenacil-related technology, a critical active ingredient in several high-value BASF herbicide products:
- • US8362026B2 — Saflufenacil-related composition and/or method claims
Developing a similar product?
Check if your herbicide formulation might infringe this or related patents.
The Verdict & Legal Analysis
Outcome
BASF Agricultural Solutions US LLC voluntarily dismissed the case against Sharda USA LLC **without prejudice** on January 6, 2026, just 43 days after filing. No damages or injunctive relief were awarded or denied by the court.
Key Legal Issues
The case was dismissed under F.R.C.P. 41(a)(1)(A)(i), meaning it closed before Sharda USA filed any responsive pleading. Therefore, there is no public judicial reasoning, claim construction order, or infringement finding on record. This highlights the strategic use of early voluntary dismissal in patent litigation, often driven by out-of-court negotiations or a reassessment of litigation strategy.
Drafting a patent for a new formulation?
Learn from this case. Use AI to draft stronger claims that can withstand litigation.
Power Your Patent Strategy with PatSnap Eureka IP
From novelty searches to patent drafting, PatSnap Eureka’s AI-powered tools help you navigate the patent landscape with confidence.
⚠️ Freedom to Operate (FTO) Analysis
This case highlights critical IP risks in agrochemical formulations. Choose your next step:
📋 Understand This Case’s Impact
Learn about the specific risks and implications from this litigation.
- View the patent family surrounding saflufenacil
- See which companies are most active in herbicide patents
- Understand claim scope in agrochemical IP
🔍 Check My Product’s Risk
Run a comprehensive FTO analysis for your own technology or product.
- Input your product description or technical features
- AI identifies potentially blocking patents
- Get actionable risk assessment report
High Risk Area
Saflufenacil-containing herbicide formulations
1 Patent at Issue
US8362026B2 (Saflufenacil)
FTO Landscape
Dynamic market with active enforcement
✅ Key Takeaways
For Patent Attorneys & Litigators
Rule 41(a)(1)(A)(i) dismissals can serve as a strategic negotiation tool without full litigation commitment.
Search related case law →Voluntary dismissal “without prejudice” preserves full rights for future enforcement actions.
Explore precedents →For R&D Teams & IP Professionals
US8362026B2 remains an active enforcement asset for BASF regarding saflufenacil formulations.
Start FTO analysis for my product →Thorough FTO analysis is crucial for generic agrochemical product development before commercial launch.
Try AI patent drafting →Ready to Strengthen Your Patent Strategy?
Join thousands of IP professionals using PatSnap Eureka to conduct prior art searches, draft patents, and analyze competitive landscapes.